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Objective. Only limited data exists in terms of the incidence of intracranial bleeding (ICB) in patients with mild traumatic brain
injury (MTBI).Methods.We retrospectively identified 3088 patients (mean age 41 range (7–99) years) presentingwith isolatedMTBI
and GCS 14-15 at our Emergency Department who had undergone cranial CT (CCT) between 2002 and 2011. Indication for CCT
was according to the “Canadian CT head rules.” Patients with ICB were either submitted for neurosurgical treatment or kept under
surveillance for at least 24 hours. Pearson’s correlation coefficient was used to correlate the incidence of ICB with age, gender, or
intake of coumarins, platelet aggregation inhibitors, or heparins. Results. 149 patients (4.8%) had ICB on CCT. No patient with ICB
died or deteriorated neurologically.The incidence of ICB increased with age and intake of anticoagulants without clinically relevant
correlation (𝑅 = 0.11; 𝑃 < 0.001; 𝑅 = −0.06; 𝑃 < 0.001). Conclusion. Our data show an incidence of 4.8% for ICB after MTBI.
However, neurological deterioration after MTBI seems to be rare, and the need for neurosurgical intervention is only required in
selected cases.The general need for CCT in patients afterMTBI is therefore questionable, and clinical surveillancemay be sufficient
when CCT is not available.
1. Introduction
Mild traumatic brain injury (MTBI) is a major public health
concern for both children and adults and represents 70–
90% of all treated traumatic brain injuries [1, 2]. Prognosis
after MTBI is a central issue in health care and is related
to both the identification of individuals at risk of poor
recovery and identification of modifiable risk factors and
feasible treatment strategies [3]. Cranial CT without contrast
(CCT) has become the gold standard to detect structural
brain injury after traumatic brain injury. Several studies have
been carried out to investigate both intracranial structural
abnormalities and clinical symptoms and neurological dete-
rioration after MTBI [4–8]. Stiell et al. reviewed more than
3000 patients undergoing CCT after MTBI in a prospec-
tive multicenter study and found clinically important brain
injuries in 8%of all cases [8].The authors proposed a score for
the performance of CCT after MTBI, and this has become
known as the Canadian CT head rules [8]. The indication for
CCT in our department is in accordance with the Canadian
CT head rules [8]. In case of an intracerebral bleed, a neuro-
surgeon has to be formally consulted. Patients with clinically
unimportant brain injury undergo admission for 24 hours
surveillance in the Emergency Department. Clinical surveil-
lance comprises the assessment of GCS every 15 minutes for
the first hour, every 30minutes for the next 2 hours, and every
hour for the following 21 hours [9]. However, it is not yet
clear whether CCT is useful for all patients with MTBI and a
Glasgow Coma Scale score (GCS) of 14-15 points, or whether
clinical surveillance may be superior [2, 8, 10–12]. This study
aimed at investigating the incidence of ICB, neurological
deterioration, and possible risk factors, in a large consecutive
group of European patients with isolated MTBI on admis-
sion.
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Table 1: Gender distribution and type of intracranial bleeding.
Characteristics All patients with ICB Female patients (%) Male patients (%)
All ICB 149 (100%) 57 (38%) 92 (62%)
Epidural haematoma 9 (6%) 2 (1%) 7 (5%)
Subdural haematoma 25 (17%) 9 (6%) 16 (11%)
Subarachnoid haemorrhage 39 (26%) 21 (14%) 18 (12%)
Intracerebral haemorrhage 76 (51%) 25 (17%) 51 (34%)
ICB: intracranial bleeding. Percentages are shown for patients with ICB.
2. Methods
A retrospective study was conducted. Using our electronic
patient records; we identified all patients presenting with
isolated MTBI and GCS 14-15 at our Emergency Department
(Level I trauma centre) between January 1, 2002 and Decem-
ber 31, 2011. All patients underwent CCT within less than 6
hours of their accident. Patients with GCS <14, missing or
incomplete CCT data, or no clear history of trauma were
excluded from the study. The indication for CCT was set
according to the guidelines of theCanadianCThead rules [8].
Diagnostic findings fromCCTwere evaluated for intracranial
bleeding (ICB). If structural brain injuries were found on
CCT, patients were either submitted for further neurosurgical
treatment or kept under surveillance for at least 24 hours, in
order to assure early recognition of neurological deterioration
related to MTBI. The type of ICB (epidural haematoma,
subdural haematoma, subarachnoid haemorrhage, or intrac-
erebral haematoma) was noted. Patients with anticoagulant
medication (coumarins, platelet aggregation inhibitors, or
heparins) were identified. The mechanisms of injury were
noted. Statistical analyses included the determination of Pear-
son’s correlation coefficient for age, gender, and the intake of
coumarins, platelet aggregation inhibitors, or heparins with
ICB [10]. A 𝑃 value <0.05 was accepted as statistically sig-
nificant. This study was approved by the institutional review
board.
3. Results
A total of 3088 patients were identified. The mean age at the
time of trauma was 41 ± 20.5 (range: 16–99) years. Sixty-one
percent of all patients were male. 149 patients (4.8%) were
found to have ICB on CCT (62% male). The different types
of ICB (epidural, subdural haematoma, subarachnoid, and
intracerebral haemorrhage) as well as gender distribution are
shown in Table 1. No patient with ICB died or deteriorated
neurologically after aminimum follow up 24 hours of clinical
surveillance.The incidence of ICB afterMTBI increased with
age and the intake of anticoagulants. However, there was no
clinically relevant correlation of ICB with age (𝑅 = 0.11;
𝑃 < 0.001), gender (𝑅 = 0.002; 𝑃 = 0.455), or the intake
of anticoagulant drugs (𝑅 = −0.06; 𝑃 < 0.001) (Figure 1).
The main mechanisms of accident were falls, road accidents,
violence, and sports.
4. Discussion
The present study aimed at investigating the incidence of ICB
afterMTBI. Of all 3088 patients, 149 (4.8%) presented with an
ICB on CCT. There were no patients with neurological dete-
rioration after 24 hours surveillance. None of the investigated
risk factors showed a clinically relevant correlation with ICB.
There is still no broad agreement in terms of the need
for CCT in patients with GCS 14-15 after MTBI [2, 8, 11–13].
Several studies have found similar results with regard to the
incidence of ICB after MTBI [8, 14, 15]. Our data suggest that
clinical surveillance seems to be sufficient and CCT may not
be necessary in the acute phase, as none of the patients in this
study presented with neurological deterioration. This would
reduce unnecessary exposure to radiation and save radiology
resources. A recent study showed that even admission and
observation are not required in a subset of adult patients
without risk factors for bleeding (e.g., anticoagulant therapy,
intoxication, and concomitant injuries), suggesting a more
liberal policy of early home monitoring [9]. On the other
hand, minor bleeding found on CCTmay guide the clinician
with regard to mid- and long-term followup, since some
patients may require elective neurological treatment due to
secondary neurocognitive disorders related to MTBI. This
may include postconcussion syndrome (PCS) [5, 7] or post-
traumatic secondary epilepsy. Several studies showed con-
siderable negative effects on the patient’s ability to return to
preinjury function, or to work or attend school after MTBI
[16–21].
5. Limitations
This study has limitations. Due to the retrospective study
design; this study includes only patients who had undergone
CCT, thus neglecting those without CCT and GCS 14-15.
For the latter, no followup was obtained and no outcome
measure can be reported. However, in accordance with our
in house policy, all patients with a history of trauma and
fulfilling the Canadian CT hear rules were included. As this
is a large patient series, we believe that this selection bias can
be neglected. Furthermore, the intake of coumarins, platelet
aggregation inhibitors, or heparins was not substantiated by
specific laboratory measures such as INR or thrombin time.
Therefore, no conclusions can be drawn with regard to the
degree of anticoagulation.
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Figure 1: The distribution of intracranial bleeding (ICB) with and without anticoagulant drugs was shown for different age groups for male
(a) and female (b) patients.The intake of anticoagulant drugs increased with increasing age. Anticoagulant drugs did not increase the risk for
ICB.
6. Conclusion
Our data show an incidence of 4.8% for ICB after MTBI.
However, neurological deterioration after MTBI seems to
be rare, and the need for neurosurgical intervention is only
required in the selected cases. Anticoagulants, age, or gender
do not seem to relevantly increase the risk of ICB. The
general need for cranial CT in patients afterMTBI is therefore
questionable, and clinical surveillancemay be sufficient when
cranial CT is not available. Nevertheless, a CCT may be
performed in patients whose comorbidities or concomitant
injuries prohibit proper clinical/neurological assessment or
surveillance.
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